← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2007Last known activity
Dec 5, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06728228CollaboratorN/ADec 5, 2024
- NCT02519335Overall official - principal investigatorPhase 1Sep 1, 2014
- NCT02519335Lead sponsorPhase 1Sep 1, 2014
- NCT01859819Study directorPhase 2Jan 1, 2013
- NCT00454818Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2007
Details
- Last known activity
- Dec 5, 2024